Join us for this insightful interview with prof. Hartmut Döhner from University Hospital Ulm in Germany who tells about most recent developments in the management of older and unfit patients with AML.
Prof. Döhner discusses all key aspects of the management including assessing patient fitness, genetic risk classification, and the choice of treatment, among which also the emerging therapies.
Tune in, to hear about the most relevant recommendations for the clinical decision making while treating older unfit patients with AML.
Host: Isabel Olivera-Martinez, PhD, Medical Writer
Guest: Prof Hartmut Döhner, University Hospital Ulm, Germany
Learn MoreWhat did you think of this podcast? Share your opinions with us in this short feedback survey.
https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1
Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.
Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.
Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/
Facebook: https://e-h-a.link/facebook
LinkedIn: https://www.linkedin.com/company/eha/
Email us: [email protected]
Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe
Fler avsnitt av EHA Unplugged
Visa alla avsnitt av EHA UnpluggedEHA Unplugged med European Hematology Association finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
